Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOPHR.L Share News (OPHR)

  • There is currently no data for OPHR

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK Earnings, Trading Statements Calendar - Next 7 Days

Thu, 06th Sep 2018 16:01

Friday 7 September 
Secure Income REITHalf Year Results 
Ashmore GroupFull Year Results 
EnquestHalf Year Results 
Greene KingTrading Statement 
Pacific Horizon Investment Trust Full Year Results 
Monday 10 September 
AbcamFull Year Results
Associated British FoodsTrading Statement 
HGCapital TrustHalf Year Results
Gulf Keystone PetroleumHalf Year Results 
BradyHalf Year Results 
Tuesday 11 September 
Ashtead GroupQ1 Results
JD Sports FashionHalf Year Results
Sanne GroupHalf Year Results
Midwich GroupHalf Year Results
Alumasc GroupFull Year Results
Vectura GroupHalf Year Results
Cairn EnergyHalf Year Results
Hilton FoodHalf Year Results
HarworthHalf Year Results
EU SupplyHalf Year Results
DP EurasiaHalf Year Results
Puretech HealthHalf Year Results
Surgical InnovationsHalf Year Results
Silence TherapeuticsHalf Year Results
Wednesday 12 September 
Galliford TryFull Year Results 
Property FranchiseHalf Year Results
iGas EnergyHalf Year Results
1pmHalf Year Results
Epwin GroupHalf Year Results
Ten EntertainmentHalf Year Results
Futura MedicalHalf Year Results
Dunelm GroupFull Year Results 
WilmingtonFull Year Results 
Medica GroupHalf Year Results
Safestore HoldingsQ3 Results
Charles TaylorHalf Year Results
Advanced Medical Solutions GroupHalf Year Results
Thursday 13 September 
GVC HoldingsHalf Year Results
WM Morrison SupermarketsHalf Year Results
Faron PharmaHalf Year Results
Oxford BiomedicaHalf Year Results
BiffaTrading Statement
Ophir EnergyHalf Year Results
RicardoFull Year Results 
Xeros TechnologyHalf Year Results
  

More News
6 Jun 2016 16:24

Ophir Energy says looking at range of equity investors for Fortuna project

CAPE TOWN, June 6 (Reuters) - Oil and gas explorer Ophir Energy Plc said on Monday it was talking to a range of equity investors, as well as gas buyers to help finance its Fortuna FLNG project in Equatorial Guinea, after Schlumberger walked away. "We've done all the work in a very difficul

Read more
6 Jun 2016 15:50

Equatorial Guinea blames Schlumberger for quitting LNG project

CAPE TOWN, June 6 (Reuters) - Equatorial Guinea's energy minister on Monday said U.S. company Schlumberger walked away from talks with Ophir over the development of the Fortuna LNG project because it wanted to "monopolise everything." But Gabriel Obiang Lima said he was confident the projec

Read more
2 Jun 2016 08:00

FTSE quarterly review confirms raft of changes to 100 and 250 indices

(ShareCast News) - Hikma Pharmaceuticals' promotion to the FTSE 100 index was confirmed after the latest quarterly review was announced overnight, while demoted blue chip Inmarsat was joined in the FTSE 250 by three recently floated finance groups CYBG, CMC Markets and Metro Bank plus several others

Read more
1 Jun 2016 17:11

Hikma to replace Inmarsat in FTSE 100 index

LONDON, June 1 (Reuters) - Hikma Pharmaceuticals will be promoted to Britain's benchmark FTSE 100 equity index after a sharp rally in its shares since March, while satellite company Inmarsat will drop out of the FTSE. A spokesman for the London Stock Exchange announced the change via telep

Read more
1 Jun 2016 16:14

Hikma Pharmaceuticals Rejoins FTSE 100, Smurfit Kappa Joins FTSE 250

Read more
31 May 2016 09:47

WINNERS & LOSERS SUMMARY: Alliance Trust Rises On RIT Approach

Read more
31 May 2016 08:29

BROKER RATINGS SUMMARY: Shore Capital Raises Brewin Dolphin To Buy

Read more
19 May 2016 15:55

LONDON MARKET CLOSE: US June Rate Hike Prospect Slams Miners

Read more
4 May 2016 08:30

BROKER RATINGS SUMMARY: Bernstein Downgrades Morrisons To Underperform

Read more
3 May 2016 15:50

Tuesday broker round-up

(ShareCast News) - Tullow Oil: Goldman Sachs upgrades to buy with a 274,30p target. RSA Insurance: Barclays upgrades to overweight with a 545p target. RBS: UBS reiterates neutral with a target price of 250p Barclays reiterates equal-weight with a target of 270p and Goldman Sachs stays at buy with 3

Read more
3 May 2016 15:15

AGM, EGM Calendar - Week Ahead

Read more
3 May 2016 08:34

BROKER RATINGS SUMMARY: UBS Downgrades RBS To Neutral From Buy

Read more
29 Apr 2016 15:51

LONDON MARKET CLOSE: RBS, IAG Lead FTSE 100 Fallers Ahead Of Break

Read more
29 Apr 2016 14:51

FTSE 250 movers: Restaurant Group sinks as revenues lift Rotork

(ShareCast News) - The FTSE 250 was down in afternoon trading on Friday, as investors picked their way through a raft of corporate earnings and as data showed the eurozone fell further into deflation in April. Valve maker Rotork was among the index leaders in afternoon trading, after it reported a 0

Read more
29 Apr 2016 11:08

LONDON MARKET MIDDAY: BoJ And Apple Hit UK Stocks Ahead Of Break

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.